23 May 2013
Keywords: amgen, initiates, gdnf, trial, parkinson, begin, first
Article | 19 August 1996
Amgen is to begin the first human clinical trial with its novel
neurotrophic factor, glial cell line-derived neurotrophic factor, for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 August 1996
5 August 1996
2 September 1996
© 2013 thepharmaletter.com